Danaher Co. (NYSE:DHR) Shares Sold by Cambridge Advisors Inc.

Cambridge Advisors Inc. reduced its stake in shares of Danaher Co. (NYSE:DHR) by 3.0% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 10,213 shares of the conglomerate’s stock after selling 313 shares during the period. Cambridge Advisors Inc.’s holdings in Danaher were worth $2,344,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of DHR. Coronation Fund Managers Ltd. boosted its holdings in Danaher by 29.9% during the second quarter. Coronation Fund Managers Ltd. now owns 6,389 shares of the conglomerate’s stock worth $1,596,000 after buying an additional 1,470 shares in the last quarter. Benjamin F. Edwards & Company Inc. raised its position in shares of Danaher by 14.8% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 10,260 shares of the conglomerate’s stock worth $2,563,000 after acquiring an additional 1,321 shares during the period. Benjamin Edwards Inc. boosted its stake in shares of Danaher by 1.8% during the 2nd quarter. Benjamin Edwards Inc. now owns 2,153 shares of the conglomerate’s stock worth $538,000 after acquiring an additional 38 shares in the last quarter. Bridges Investment Management Inc. acquired a new stake in shares of Danaher during the 2nd quarter valued at about $240,000. Finally, AE Wealth Management LLC increased its stake in shares of Danaher by 10.8% in the 2nd quarter. AE Wealth Management LLC now owns 15,619 shares of the conglomerate’s stock valued at $3,903,000 after purchasing an additional 1,518 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have issued reports on DHR shares. Scotiabank started coverage on Danaher in a research report on Monday, December 23rd. They set a “sector perform” rating and a $265.00 price target on the stock. Raymond James decreased their target price on Danaher from $310.00 to $300.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 23rd. StockNews.com lowered shares of Danaher from a “buy” rating to a “hold” rating in a report on Saturday, December 14th. Evercore ISI lifted their target price on shares of Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a research report on Tuesday, October 1st. Finally, Guggenheim began coverage on shares of Danaher in a research note on Thursday, December 19th. They set a “buy” rating and a $275.00 target price for the company. Six analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $286.80.

Danaher Trading Down 1.4 %

Shares of DHR stock opened at $238.41 on Friday. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. Danaher Co. has a twelve month low of $222.53 and a twelve month high of $281.70. The company’s 50-day moving average price is $234.85 and its 200-day moving average price is $253.32. The stock has a market cap of $172.20 billion, a price-to-earnings ratio of 45.50, a PEG ratio of 4.23 and a beta of 0.83.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, beating the consensus estimate of $1.57 by $0.14. The company had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. Danaher’s revenue was up 3.1% on a year-over-year basis. During the same period in the previous year, the business posted $2.02 EPS. As a group, equities analysts predict that Danaher Co. will post 7.49 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be paid a dividend of $0.27 per share. The ex-dividend date of this dividend is Friday, December 27th. This represents a $1.08 annualized dividend and a yield of 0.45%. Danaher’s dividend payout ratio (DPR) is 20.61%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.